<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">avk</journal-id><journal-title-group><journal-title xml:lang="ru">Архивъ внутренней медицины</journal-title><trans-title-group xml:lang="en"><trans-title>The Russian Archives of Internal Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-6704</issn><issn pub-type="epub">2411-6564</issn><publisher><publisher-name>“SINAPS” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20514/2226-6704-2018-8-6-418-423</article-id><article-id custom-type="elpub" pub-id-type="custom">avk-849</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>СТРАТИФИКАЦИЯ НЕФРОЦЕРЕБРАЛЬНОГО И СЕРДЕЧНО-СОСУДИСТОГО РИСКА ПРИ ХРОНИЧЕСКИХ ГЛОМЕРУЛОНЕФРИТАХ (ОБЗОР ЛИТЕРАТУРЫ)</article-title><trans-title-group xml:lang="en"><trans-title>STRATIFICATION OF NEPHROCEREBRAL AND CARDIOVASCULAR RISK IN CHRONIC GLOMERULONEPHRITIS (LITERATURE REVIEW)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муркамилов</surname><given-names>И. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Murkamilov</surname><given-names>I. T.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">murkamilov.i@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сабиров</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sabirov</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муркамилова</surname><given-names>Ж. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Murkamilova</surname><given-names>Zh. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сабирова</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sabirova</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Айтбаев</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Aitbaev</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иманов</surname><given-names>Б. Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Imanov</surname><given-names>B. Zh.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Реджапова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Redzhapova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юсупов</surname><given-names>Ф. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yusupov</surname><given-names>F. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-7"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кыргызская государственная медицинская академия имени И.К. Ахунбаева;&#13;
Кыргызско-Российский Славянский университет имени первого Президента России Б.Н. Ельцина</institution><country>Кыргызстан</country></aff><aff xml:lang="en"><institution>Kyrgyz State Medical Academy named after I.K. Akhunbaev;&#13;
Kyrgyz Russian Slavic University named after the First President of Russia B.N. Yeltsin</institution><country>Kyrgyzstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Кыргызско-Российский Славянский университет имени первого Президента России Б.Н. Ельцина</institution><country>Кыргызстан</country></aff><aff xml:lang="en"><institution>Kyrgyz Russian Slavic University named after the First President of Russia B.N. Yeltsin</institution><country>Kyrgyzstan</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Центр семейной медицины № 7</institution><country>Кыргызстан</country></aff><aff xml:lang="en"><institution>Family Medicine Center № 7</institution><country>Kyrgyzstan</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>SAEI HE First Moscow State Medical University named after I.M. Sechenov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Научно-исследовательский институт молекулярной биологии и медицины</institution><country>Кыргызстан</country></aff><aff xml:lang="en"><institution>Scientific and research Institute of molecular biology and medicine</institution><country>Kyrgyzstan</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Национальный Центр кардиологии и терапии имени академика Мирсаида Миррахимова</institution><country>Кыргызстан</country></aff><aff xml:lang="en"><institution>National Cardiology and Therapy Center named after academician Mirsaid Mirrahimov, Bishkek, Kyrgyzstan</institution><country>Kyrgyzstan</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>Ошский государственный университет</institution><country>Кыргызстан</country></aff><aff xml:lang="en"><institution>Osh State University</institution><country>Kyrgyzstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>02</day><month>12</month><year>2018</year></pub-date><volume>8</volume><issue>6</issue><fpage>418</fpage><lpage>423</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Муркамилов И.Т., Сабиров И.С., Муркамилова Ж.А., Фомин В.В., Сабирова А.И., Айтбаев К.А., Иманов Б.Ж., Реджапова Н.А., Юсупов Ф.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Муркамилов И.Т., Сабиров И.С., Муркамилова Ж.А., Фомин В.В., Сабирова А.И., Айтбаев К.А., Иманов Б.Ж., Реджапова Н.А., Юсупов Ф.А.</copyright-holder><copyright-holder xml:lang="en">Murkamilov I.T., Sabirov I.S., Murkamilova Z.A., Fomin V.V., Sabirova A.I., Aitbaev K.A., Imanov B.Z., Redzhapova N.A., Yusupov F.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medarhive.ru/jour/article/view/849">https://www.medarhive.ru/jour/article/view/849</self-uri><abstract><p>В статье проведен анализ данных литературы, касающихся вопросов возникновения и прогрессирования цереброваскулярных и кардиальных заболеваний при ренальной дисфункции. Сердечно-сосудистые заболевания и хроническая болезнь почек имеют общие «традиционные» факторы риска, при этом рост численности популяции больных с почечными нарушениями в настоящее время происходит, в основном, за счет вторичного повреждения почек в рамках таких социально значимых заболеваний как ожирение, артериальной гипертензии, атеросклероза, сахарного диабета 2-го типа, ишемической болезни сердца и хронической сердечной недостаточности. Представленные данные научных исследований свидетельствуют о прямой корреляционной взаимосвязи снижения ренальной функции с увеличением риска кардио и цереброваскулярных заболеваний и смерти независимо от других факторов риска. Ожирение и связанные с ним биологические субстраты являются самостоятельными факторами риска стойкого ухудшения функции почек; увеличение индекса массы тела вызывает прямое повреждение почек, вследствие нарушенного синтеза жировой тканью различных цитокинов с нефротоксическим действием, а также опосредованное — за счет индукции развития сахарного диабета 2-го типа и артериальной гипертензии, являющихся наиболее частыми факторами риска хронической болезни почек и сердечно-сосудистых заболеваний. Представлены данные исследований о роли эндотелиальной дисфункии в нарушении ренальной функции, что способствует формированию атеросклероза, а нарастание выраженности атеросклеротического процесса содействует увеличению тяжести почечной недостаточности. Также представлены литературные данные о значении частоты сердечных сокращений. Прирост частоты сердечных сокращений может приводить к атеросклеротическому уплотнению артерий, которое ассоциируется с возрастанием скорости распространения пульсовой волны с нарушением механизмов ауторегуляции кровотока в головном мозге и почках.</p></abstract><trans-abstract xml:lang="en"><p>This article analyzes the literature data concerning the origin and progression of cerebrovascular and cardiac diseases in renal dysfunction. Cardiovascular diseases and chronic kidney disease have common “traditional” risk factors, while the population growth in patients with renal impairment is currently mainly due to secondary renal damage in socially important diseases such as obesity, hypertension, atherosclerosis, type 2 diabetes, ischemic heart disease and chronic heart failure. The presented data of scientific researches testify to the direct correlation correlation between the decrease of the renal function and the increased risk of cardioand cerebrovascular diseases and death, irrespective of other risk factors. Obesity and associated biological substrates are independent risk factors for persistent impairment of kidney function and an increase in the body mass index causes direct damage to the kidneys, due to the disrupted synthesis of fat cytokines by various cytokines with nephrotoxic action, and also mediated — by inducing the development of diabetes mellitus 2 type and arterial hypertension, which are the most frequent risk factors for chronic kidney disease and cardiovascular diseases. The presented data on the role of endothelial dysfunction in impaired renal function, which contributes to the formation of atherosclerosis, and the increase in the severity of the atherosclerotic process contributes to an increase in the sever ity of renal failure. Literature data on the value of the heart rate are also presented. The increase in the heart rate can lead to atherosclerotic densification of the arteries, which is associated with an increase in the rate of spread of the pulse wave with a violation of the mechanisms of autoregulation of the blood flow in the brain and kidneys.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая болезнь почек</kwd><kwd>скорость клубочковой фильтрации</kwd><kwd>факторы риска</kwd><kwd>сердечно-сосудистый риск</kwd><kwd>цереброваскулярные заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic kidney disease</kwd><kwd>glomerular filtration rate</kwd><kwd>risk factors</kwd><kwd>cardiovascular risk</kwd><kwd>cerebro-vascular diseases</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Моисеев В.С., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Российский кардиологический журнал. 2014; 8: 7-37. DOI:10.15829/1560-4071-2014-8-7-37.</mixed-citation><mixed-citation xml:lang="en">. Moiseev V.S., Mukhin N.A, Smirnov A.V. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Journal of Cardiology. 2014; 8: 7-37. DOI:10.15829/1560-4071-2014-8-7-37 [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mark P.B. Strategies to manage cardiovascular risk in chronic kidney disease. Nephrology Dialysis Transplantation. 2017; 33(1): 23-25. DOI:https://doi.org/10.1093/ndt/gfx329.</mixed-citation><mixed-citation xml:lang="en">Mark P.B. Strategies to manage cardiovascular risk in chronic kidney disease. Nephrology Dialysis Transplantation. 2017; 33(1): 23-25. DOI:https://doi.org/10.1093/ndt/gfx329.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Stenvinkel P., Zoccali C., Ikizler T.A. Obesity in CKD-what should nephrologists know? Journal of the American Society of Nephrology. 2013; 24(11): 1727-1736. DOI:10.1681/ASN.2013040330.</mixed-citation><mixed-citation xml:lang="en">Stenvinkel P., Zoccali C., Ikizler T.A. Obesity in CKD-what should nephrologists know? Journal of the American Society of Nephrology. 2013; 24(11): 1727-1736. DOI:10.1681/ASN.2013040330.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bouquegneau A., Vidal-Petiot E., Moranne O. et al. Creatinine-based equations for the adjustment of drug dosage in an obese population. British journal of clinical pharmacology. 2016; 81(2): 349-361. DOI:https://doi.org/10.1111/bcp.12817.</mixed-citation><mixed-citation xml:lang="en">Bouquegneau A., Vidal-Petiot E., Moranne O. et al. Creatinine-based equations for the adjustment of drug dosage in an obese population. British journal of clinical pharmacology. 2016; 81(2): 349-361. DOI:https://doi.org/10.1111/bcp.12817.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Levey A.S., Rocco M.V., Anderson S. et al. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal of Kidney Diseases. 2004; 43: 5. Suppl.1.</mixed-citation><mixed-citation xml:lang="en">Levey A.S., Rocco M.V., Anderson S. et al. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal of Kidney Diseases. 2004; 43: 5. Suppl.1.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Недогода С.В., Жернакова Ю.В. и др. Рекомендации по ведению больных артериальной гипертонией с метаболическими нарушениями. Кардиологический вестник. 2014; 9(1): 3-57.</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Nedogoda S.V., Zhernakova Iu.V. et al. Guidelines for management of patients with arterial hypertension and metabolic disorders. Cardiological bulletin. 2014; 9(1): 3-57. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lamprea-Montealegre J.A., Astor B.C., McClelland R.L. et al. CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis. Clinical Journal of the American Society of Nephrology. 2012; CJN. 02090212. DOI:10.2215/CJN.02090212.</mixed-citation><mixed-citation xml:lang="en">Lamprea-Montealegre J.A., Astor B.C., McClelland R.L. et al. CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis. Clinical Journal of the American Society of Nephrology. 2012; CJN. 02090212. DOI:10.2215/CJN.02090212.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Волков М.М., Дегтерева О.А., Смирнов А.В. и др. Атеросклероз как основной фактор кальциноза клапанного аппарата сердца в додиализном периоде хронической болезни почек. Нефрология. 2007; 11(4):47-54.</mixed-citation><mixed-citation xml:lang="en">Volkov M.M., Degtereva O.A., Smirnov A.V. et al. Atheroclerosis as the main factor of calcinosis of the heart valve apparatus in the predialysis period of chronic kidney disease. Nephrology. 2007; 11(4): 47-54. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 8-й выпуск. М. 2017. ФГБУ «НМИЦ эндокринологии Минздрава России» [Электронный ресурс. Дата обращения: 28.08.2018]. 20:1S:1-112. DOI: 10.14341/DM20171S8.</mixed-citation><mixed-citation xml:lang="en">Algorithms of specialized medical care for patients with diabetes mellitus. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 8th edition. M. 2017. FSBI «NMIC Endocrinology of the Ministry of Health of Russia» [Electronic resource. date of the application: 28.08.2018]. 20:1S:1-112. DOI: 10.14341/DM20171S8. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Whaley-Connell A.A., Sowers J.R., McCullough P.A. et al. KEEP Investigators. Diabetes mellitus and CKD awareness: the kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES). American Journal of Kidney Diseases. 2009; 53(4): S11-S21. DOI: https://doi.org/10.1053/j.ajkd.2009.01.004.</mixed-citation><mixed-citation xml:lang="en">Whaley-Connell A.A., Sowers J.R., McCullough P.A. et al. KEEP Investigators. Diabetes mellitus and CKD awareness: the kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES). American Journal of Kidney Diseases. 2009; 53(4): S11-S21. DOI: https://doi.org/10.1053/j.ajkd.2009.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sarnak M.J., Levey A.S., Schoolwerth A.C. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108: 17: 2154-2169. DOI:https://doi.org/10.1161/01.CIR.0000095676.90936.80.</mixed-citation><mixed-citation xml:lang="en">Sarnak M.J., Levey A.S., Schoolwerth A.C. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108: 17: 2154-2169. DOI:https://doi.org/10.1161/01.CIR.0000095676.90936.80.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Levin A. The clinical epidemiology of cardiovascular diseases in chronic kidney disease: clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Seminars in dialysis. Oxford, UK: Blackwell Science Inc. 2003; 16(2): 101-105. DOI:https://doi.org/10.1046/j.1525-139X.2003.16025.x.</mixed-citation><mixed-citation xml:lang="en">Levin A. The clinical epidemiology of cardiovascular diseases in chronic kidney disease: clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Seminars in dialysis. Oxford, UK: Blackwell Science Inc. 2003; 16(2): 101-105. DOI:https://doi.org/10.1046/j.1525-139X.2003.16025.x.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Серов В.А., Шутов А.М., Мензоров М.В. и др. Эпидемиология хронической болезни почек у больных с хронической сердечной недостаточностью. Нефрология. 2010; 14(1): 50-55.</mixed-citation><mixed-citation xml:lang="en">Serov V.A., Shutov A.M., Menzorov M.V. et al. Epidemiology of chronic kidney disease patients with chronic heart failure. Nephrology. 2010; 14(1): 50-55. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Crowley M.J., Diamantidis C.J., McDuffie J.R. et al. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review. Annals of internal medicine. 2017; 166(3): 191-200. DOI:10.7326/M16-1901.</mixed-citation><mixed-citation xml:lang="en">Crowley M.J., Diamantidis C.J., McDuffie J.R. et al. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review. Annals of internal medicine. 2017; 166(3): 191-200. DOI:10.7326/M16-1901.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004; 351(13): 1296-1305. DOI:10.1056/NEJMoa041031.</mixed-citation><mixed-citation xml:lang="en">Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004; 351(13): 1296-1305. DOI:10.1056/NEJMoa041031.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dong Y., Wang Z., Chen Z. et al. Comparison of visceral, body fat indices and anthropometric measures in relation to chronic kidney disease among Chinese adults from a large-scale cross-sectional study. BMC nephrology. 2018; 19(1): 40. DOI:https://doi.org/10.1186/s12882-018-0837-1.</mixed-citation><mixed-citation xml:lang="en">Dong Y., Wang Z., Chen Z. et al. Comparison of visceral, body fat indices and anthropometric measures in relation to chronic kidney disease among Chinese adults from a large-scale cross-sectional study. BMC nephrology. 2018; 19(1): 40. DOI:https://doi.org/10.1186/s12882-018-0837-1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Despres J.P. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J. 2006; 8(suppl.B): 4-12. DOI:https://doi.org/10.1093/eurheartj/sul002.</mixed-citation><mixed-citation xml:lang="en">Despres J.P. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J. 2006; 8(suppl.B): 4-12. DOI:https://doi.org/10.1093/eurheartj/sul002.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kambham N., Markowitz G.S., Valeri A.M. et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001; 59(4): 14981509. DOI:https://doi.org/10.1046/j.1523-1755.2001.0590041498.x.</mixed-citation><mixed-citation xml:lang="en">Kambham N., Markowitz G.S., Valeri A.M. et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001; 59(4): 14981509. DOI:https://doi.org/10.1046/j.1523-1755.2001.0590041498.x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Foster M.C, Hwang S.J., Massaro J.M. et al. Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring). 2011; 19(6): 12841289. DOI:https://doi.org/10.1038/oby.2010.308.</mixed-citation><mixed-citation xml:lang="en">Foster M.C, Hwang S.J., Massaro J.M. et al. Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring). 2011; 19(6): 12841289. DOI:https://doi.org/10.1038/oby.2010.308.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kovesdy C.P., Furth S., Zoccali C. World Kidney Day Steering Committee.Obesity and kidney disease: hidden consequences of the epidemic. Journal of Endocrinology, Metabolism and Diabetes of South Africa. 2017; 22(1): 5-11. DOI:https://doi.org/10.1080/16089677.2017.1299975.</mixed-citation><mixed-citation xml:lang="en">Kovesdy C.P., Furth S., Zoccali C. World Kidney Day Steering Committee.Obesity and kidney disease: hidden consequences of the epidemic. Journal of Endocrinology, Metabolism and Diabetes of South Africa. 2017; 22(1): 5-11. DOI:https://doi.org/10.1080/16089677.2017.1299975.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clinica chimica acta. 2010; 411(19-20): 1412-1420. DOI:https://doi.org/10.1016/j.cca.2010.06.019.</mixed-citation><mixed-citation xml:lang="en">Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clinica chimica acta. 2010; 411(19-20): 1412-1420. DOI:https://doi.org/10.1016/j.cca.2010.06.019.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Briffa J.F., McAinch A.J., Poronnik P., &amp; Hryciw D.H. Adipokines as a link between obesity and chronic kidney disease. American Journal of Physiology-Renal Physiology. 2013; 305: 12: F1629-F1636. DOI:https://doi.org/10.1152/ajprenal.00263.2013.</mixed-citation><mixed-citation xml:lang="en">Briffa J.F., McAinch A.J., Poronnik P., &amp; Hryciw D.H. Adipokines as a link between obesity and chronic kidney disease. American Journal of Physiology-Renal Physiology. 2013; 305: 12: F1629-F1636. DOI:https://doi.org/10.1152/ajprenal.00263.2013.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии. 2010; 3: 5–26.</mixed-citation><mixed-citation xml:lang="en">Diagnostics and treatment of arterial hypertension. Russian recommendations (the fourth revision). Systemic hypertension. 2010; 3: 5–26. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mathew R.O., Bangalore S., Lavelle M.P. et al. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. Kidney international. 2017; 91(4): 797-807. DOI:https://doi.org/10.1016/j.kint.2016.09.049.</mixed-citation><mixed-citation xml:lang="en">Mathew R.O., Bangalore S., Lavelle M.P. et al. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. Kidney international. 2017; 91(4): 797-807. DOI:https://doi.org/10.1016/j.kint.2016.09.049.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yu F.P., Zhao Y.C., Gu B. et al. Chronic Kidney Disease and Carotid Atherosclerosis in Patients with Acute Stroke. The neurologist. 2015; 20(2): 23-26. DOI:10.1097/NRL.0000000000000044.</mixed-citation><mixed-citation xml:lang="en">Yu F.P., Zhao Y.C., Gu B. et al. Chronic Kidney Disease and Carotid Atherosclerosis in Patients with Acute Stroke. The neurologist. 2015; 20(2): 23-26. DOI:10.1097/NRL.0000000000000044.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Фомин В.В., Моисеев С.В., Швецов М.Ю. и др. Артериальная гипертония при ишемической болезни почек: клинические особенности и течение. Тер. архив. 2005; 77(6): 27-32.</mixed-citation><mixed-citation xml:lang="en">Fomin V.V., Moiseev S.V., Shvetsov M.Yu. et al. Arterial hypertension in clinical assessment of ischemic renal disease. Ther. аrchive. 2005; 77(6): 27-32. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Фомин В.В. Ишемическая болезнь почек: клинико-патогенетическое особенности, диагностика, лечение. Клиническая медицина. 2008; 86(4):8-14.</mixed-citation><mixed-citation xml:lang="en">Fomin V.V. Ischemic kidney disease: clinical and pathogenetic features, diagnostics, treatment. Clinical medicine. 2008; 86(4): 8-14. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Siew E.D., Ikizler T.A. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Seminars in dialysis.Oxford, UK: Blackwell Publishing Ltd. 2010; 23(4): 378-382. DOI:https://doi.org/10.1111/j.1525-139X.2010.00763.x.</mixed-citation><mixed-citation xml:lang="en">Siew E.D., Ikizler T.A. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Seminars in dialysis.Oxford, UK: Blackwell Publishing Ltd. 2010; 23(4): 378-382. DOI:https://doi.org/10.1111/j.1525-139X.2010.00763.x.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Longstreth W.T.Jr., Manolio T.A., Arnold A. et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996; 27(8): 1274–1282. DOI: 10.1161/01.STR.27.8.1274.</mixed-citation><mixed-citation xml:lang="en">Longstreth W.T.Jr., Manolio T.A., Arnold A. et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996; 27(8): 1274–1282. DOI: 10.1161/01.STR.27.8.1274.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Vermeer S.E., Longstreth W.T.Jr., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurology. 2007; 6(7): 611-619. DOI:https://doi.org/10.1016/S1474-4422(07)70170-9.</mixed-citation><mixed-citation xml:lang="en">Vermeer S.E., Longstreth W.T.Jr., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurology. 2007; 6(7): 611-619. DOI:https://doi.org/10.1016/S1474-4422(07)70170-9.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Wong T.Y., Klein R., Sharrett A.R. et al. Cerebral white matter lesions, retinopathy and incident clinical stroke. JAMA. 2002; 288(1): 67–74. DOI:10.1001/jama.288.1.67.</mixed-citation><mixed-citation xml:lang="en">Wong T.Y., Klein R., Sharrett A.R. et al. Cerebral white matter lesions, retinopathy and incident clinical stroke. JAMA. 2002; 288(1): 67–74. DOI:10.1001/jama.288.1.67.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Buyck J.F., Dufouil C., Mazoyer B. et al. Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study. Stroke. 2009; 40(7): 2327–2331. DOI: 10.1161/STROKEAHA.109.548222.</mixed-citation><mixed-citation xml:lang="en">Buyck J.F., Dufouil C., Mazoyer B. et al. Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study. Stroke. 2009; 40(7): 2327–2331. DOI: 10.1161/STROKEAHA.109.548222.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kearney-Schwartz A., Rossignol P., Bracard S. et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009; 40(4): 1229-1236. DOI: 10.1161/STROKEAHA.108.532853.</mixed-citation><mixed-citation xml:lang="en">Kearney-Schwartz A., Rossignol P., Bracard S. et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009; 40(4): 1229-1236. DOI: 10.1161/STROKEAHA.108.532853.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Rao M.V., Qiu Y., Wang C., Bakris G. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am. J. Kidney Dis. 2008; 51(4): S30-S37. DOI:https://doi.org/10.1053/j.ajkd.2007.12.012.</mixed-citation><mixed-citation xml:lang="en">Rao M.V., Qiu Y., Wang C., Bakris G. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am. J. Kidney Dis. 2008; 51(4): S30-S37. DOI:https://doi.org/10.1053/j.ajkd.2007.12.012.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Rimoldi S.F., Scherrer U., Messerli F.H. Secondary arterial hypertension: when, who, and how to screen? Eur. Heart J. 2013; 35(19): 1245-1254. DOI:https://doi.org/10.1093/eurheartj/eht534.</mixed-citation><mixed-citation xml:lang="en">Rimoldi S.F., Scherrer U., Messerli F.H. Secondary arterial hypertension: when, who, and how to screen? Eur. Heart J. 2013; 35(19): 1245-1254. DOI:https://doi.org/10.1093/eurheartj/eht534.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Franczyk B., Gluba-Brzózka A., Banach M., &amp; Rysz J. The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease. Current vascular pharmacology. 2016; 14(3): 260-265.</mixed-citation><mixed-citation xml:lang="en">Franczyk B., Gluba-Brzózka A., Banach M., &amp; Rysz J. The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease. Current vascular pharmacology. 2016; 14(3): 260-265.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Naser N., Dilic M., Durak A. et al. The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation. Materia sociomedica. 2017; 29(4): 231-236. DOI:10.5455/msm.2017.29.231-236.</mixed-citation><mixed-citation xml:lang="en">Naser N., Dilic M., Durak A. et al. The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation. Materia sociomedica. 2017; 29(4): 231-236. DOI:10.5455/msm.2017.29.231-236.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016; 37: 2893-2962. DOI:https://doi.org/10.1093/eurheartj/ehw210.</mixed-citation><mixed-citation xml:lang="en">Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016; 37: 2893-2962. DOI:https://doi.org/10.1093/eurheartj/ehw210.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Piccini J.P., Stevens S.R., Chang Y. et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Circulation. 2013; 127(2): 224-232. DOI: 10.1161/CIRCULATIONAHA.112.107128.</mixed-citation><mixed-citation xml:lang="en">Piccini J.P., Stevens S.R., Chang Y. et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Circulation. 2013; 127(2): 224-232. DOI: 10.1161/CIRCULATIONAHA.112.107128.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Wu G., Cheng M., Huang H. et al. A variant of IL6R is associated with the recurrence of atrial fibrillation after catheter ablation in a Chinese Han population. PloS one. 2014; 9: 6: e99623. DOI:https://doi.org/10.1371/journal.pone.0099623.</mixed-citation><mixed-citation xml:lang="en">Wu G., Cheng M., Huang H. et al. A variant of IL6R is associated with the recurrence of atrial fibrillation after catheter ablation in a Chinese Han population. PloS one. 2014; 9: 6: e99623. DOI:https://doi.org/10.1371/journal.pone.0099623.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bansal N., Xie D., Tao K. et al. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clinical Journal of the American Society of Nephrology. 2016; CJN. 10921015. DOI:10.2215/CJN.10921015.</mixed-citation><mixed-citation xml:lang="en">Bansal N., Xie D., Tao K. et al. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clinical Journal of the American Society of Nephrology. 2016; CJN. 10921015. DOI:10.2215/CJN.10921015.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Olesen J.B., Lip G.Y., Kamper A.L. et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. New England Journal of Medicine. 2012; 367(7): 625-635. DOI: 10.1056/NEJMoa1105594.</mixed-citation><mixed-citation xml:lang="en">Olesen J.B., Lip G.Y., Kamper A.L. et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. New England Journal of Medicine. 2012; 367(7): 625-635. DOI: 10.1056/NEJMoa1105594.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">The European Stroke Organization (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attacks. 2008. Cerebrovasc Dis. 2008; 25(5): 457–507. DOI: 10.1159/000131083.</mixed-citation><mixed-citation xml:lang="en">The European Stroke Organization (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attacks. 2008. Cerebrovasc Dis. 2008; 25(5): 457–507. DOI: 10.1159/000131083.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Rashid R., Leonardi-Bee J., Bath Ph. Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review. Stroke. 2003; 34(11): 2741-2748. DOI: http://dx.doi.org/10.1161/01.STR.0000092488.</mixed-citation><mixed-citation xml:lang="en">Rashid R., Leonardi-Bee J., Bath Ph. Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review. Stroke. 2003; 34(11): 2741-2748. DOI: http://dx.doi.org/10.1161/01.STR.0000092488.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Nambi V., Chambless L., Folsom A.R. et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2010; 55(15): 1600-1607. DOI: 10.1016/j.jacc.2009.11.075.</mixed-citation><mixed-citation xml:lang="en">Nambi V., Chambless L., Folsom A.R. et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2010; 55(15): 1600-1607. DOI: 10.1016/j.jacc.2009.11.075.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Zanchetti A., Bond M.G., Hennig M. et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation. 2002; 106(19): 2422–2427.</mixed-citation><mixed-citation xml:lang="en">Zanchetti A., Bond M.G., Hennig M. et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation. 2002; 106(19): 2422–2427.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Perticone F., Ceravolo R., Pujia A. et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001; 104(2): 191-196.</mixed-citation><mixed-citation xml:lang="en">Perticone F., Ceravolo R., Pujia A. et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001; 104(2): 191-196.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Tonelli M., Sacks F., Pfeffer M.et al. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005; 68(1): 237245. DOI:https://doi.org/10.1111/j.1523-1755.2005.00398.x.</mixed-citation><mixed-citation xml:lang="en">Tonelli M., Sacks F., Pfeffer M.et al. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005; 68(1): 237245. DOI:https://doi.org/10.1111/j.1523-1755.2005.00398.x.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Dounousi E., Koliousi E. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease. Am J Nephrol. 2012; 36(6): 531-536. DOI:https://doi.org/10.1159/000345352.</mixed-citation><mixed-citation xml:lang="en">Dounousi E., Koliousi E. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease. Am J Nephrol. 2012; 36(6): 531-536. DOI:https://doi.org/10.1159/000345352.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Муркамилов И.Т., Айтбаев К.А., Фомин В.В., Юсупов Ф.А. Субклиническое ремоделирование каротидных артерий при хроническом гломерулонефрите. Архивъ внутренней медицины. 2017; 7(4): 300-305. DOI: https://doi.org/10.20514/2226-6704-2017-7-4300-305.</mixed-citation><mixed-citation xml:lang="en">Murkamilov I.T., Aitbaev R.A., Fomin V.V., Yusupov F.A. Subclinical lesion of carotid arteries in chronic glomerulonephritis. The Russian Archives of Internal Medicine. 2017; 7(4): 300-305. DOI: https://doi.org/10.20514/2226-6704-2017-7-4-300-305. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Муркамилов И.Т., Сабиров И.С., Фомин В.В. и др. Оценка нефроцеребрального риска с использованием цистатина С у больных хронической болезнью почек. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018; 118(9): 10-16. DOI: https://doi.org/10.17116/jnevro201811809110.</mixed-citation><mixed-citation xml:lang="en">Murkamilov I.T., Sabirov I.S., Fomin V.V., Murkamilova Zh.A., Aytbaev K.A., Rayimzhanov Z.R. Evaluation of nephrocerebral risk using cystatin C in patients with chronic kidney disease. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2018; 118(9): 10-16. DOI:https://doi.org/10.17116/jnevro201811809110. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Пьянкина О.В., Татаринцев П.Б., Рагозин О.Н. Влияние уремических факторов на процессы ремоделирования периферических сосудов у больных хронической болезнью почек. Современные проблемы науки и образования. 2013; 1: URL: http.V/www.scienceeducation.ru/107-8509. Электронный ресурс. Дата обращения: 28.08.2018</mixed-citation><mixed-citation xml:lang="en">Pyankina O.V., Tatarintsev P.B., Ragozin O.N. Influence of uremic factors in the processes of remodeling of peripheral vessels in patients with chronic kidney disease. Modern problems of science and education. 2013; 1: URL: https://science-education.ru/en/article/view?id=8509. Electronic resource. Date of the application: 28.08.2018. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Pelisek J., Hahntow I.N., Eckstein H.H. Impact of chronic kidney disease on carotid plaque vulnerability. J Vasc Surg. 2011; 54(6): 16431649. DOI:https://doi.org/10.1016/j.jvs.2011.05.049</mixed-citation><mixed-citation xml:lang="en">Pelisek J., Hahntow I.N., Eckstein H.H. Impact of chronic kidney disease on carotid plaque vulnerability. J Vasc Surg. 2011; 54(6): 16431649. DOI:https://doi.org/10.1016/j.jvs.2011.05.049</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Levine H.J. Rest heart rate and life expectancy. Journal of the American College of Cardiology. 1997; 30(4): 1104-1106.</mixed-citation><mixed-citation xml:lang="en">Levine H.J. Rest heart rate and life expectancy. Journal of the American College of Cardiology. 1997; 30(4): 1104-1106.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Levy R.L., White P.D., Stroud W.D., Hillman C.C. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA. 1945; 129(9): 585-588. DOI:10.1001/jama.1945.02860430001001.</mixed-citation><mixed-citation xml:lang="en">Levy R.L., White P.D., Stroud W.D., Hillman C.C. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA. 1945; 129(9): 585-588. DOI:10.1001/jama.1945.02860430001001.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Gillman M., Kannel W., Belanger A., D`Agostino R. Influence of heart rate on mortality among persons with hypertension: The Framingam study Am Heart J. 1993; 125(4): 1148-1154. DOI: https://doi.org/10.1016/0002-8703(93)90128-V.</mixed-citation><mixed-citation xml:lang="en">Gillman M., Kannel W., Belanger A., D`Agostino R. Influence of heart rate on mortality among persons with hypertension: The Framingam study Am Heart J. 1993; 125(4): 1148-1154. DOI: https://doi.org/10.1016/0002-8703(93)90128-V.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz R.J. The neural control of heart rate and risk stratification after myocardial infarction. Eur Heart J. 1999; 1 (Suppl H): H33-H43.</mixed-citation><mixed-citation xml:lang="en">Schwartz R.J. The neural control of heart rate and risk stratification after myocardial infarction. Eur Heart J. 1999; 1 (Suppl H): H33-H43.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Fusrer V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (I). N Engl J Med. 1992; 326(4): 242-250. DOI: 10.1056/NEJM199201233260406.</mixed-citation><mixed-citation xml:lang="en">Fusrer V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (I). N Engl J Med. 1992; 326(4): 242-250. DOI: 10.1056/NEJM199201233260406.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Copie X., Hnatkova K., Staunton A. et al. Predictive Power of Increased Heart Rate Versus Depressed Left Ventricular Ejection Fraction and Heart Rate Variability for Risk Stratification After Myocardial Infarction. J Am Coll Cardiol. 1996; 27: 270-276. DOI: 10.1016/07351097(95)00454-8.</mixed-citation><mixed-citation xml:lang="en">Copie X., Hnatkova K., Staunton A. et al. Predictive Power of Increased Heart Rate Versus Depressed Left Ventricular Ejection Fraction and Heart Rate Variability for Risk Stratification After Myocardial Infarction. J Am Coll Cardiol. 1996; 27: 270-276. DOI: 10.1016/07351097(95)00454-8.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Bonaa K.H., Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population. The Tromso Study. Circulation. 1992; 86: 394-405. PMID:1638708.</mixed-citation><mixed-citation xml:lang="en">Bonaa K.H., Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population. The Tromso Study. Circulation. 1992; 86: 394-405. PMID:1638708.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Perski A., Hamsten A., Lindvall K., Theorell T. Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients. Am Heart J. 1988; 116(5): 1369-1373. DOI:https://doi.org/10.1016/0002-8703(88)90469-3.</mixed-citation><mixed-citation xml:lang="en">Perski A., Hamsten A., Lindvall K., Theorell T. Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients. Am Heart J. 1988; 116(5): 1369-1373. DOI:https://doi.org/10.1016/0002-8703(88)90469-3.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Perski A., Olsson G., Landou C. et al. Minimum teart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesion in men with myocardial infarction at a young age. Am Heart J. 1992; 123(3): 609-616. DOI:https://doi.org/10.1016/0002-8703(92)90497-J.</mixed-citation><mixed-citation xml:lang="en">Perski A., Olsson G., Landou C. et al. Minimum teart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesion in men with myocardial infarction at a young age. Am Heart J. 1992; 123(3): 609-616. DOI:https://doi.org/10.1016/0002-8703(92)90497-J.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
